Convened and run by QUT, The Bridge Program is also supported by the government body MTPConnect, with industry matched funding to deliver this exciting education program that provides the necessary training to enable successful commercialisation of Australian pharmaceutical research.
Along with MTPConnect and QUT, The Bridge Program involves support and input from a consortium of pharmaceutical companies, universities and industry associations and is the outcome of a growing sector wanting to propel its status on the national and international market as a leader in the innovation economy.
This project is supported by MTPConnect, through its Medical Research Future Fund’s Biomedical Translation Bridge program. Learn more at mtpconnect.org.au